Skip to main content
← Back to all earnings calls

Karyopharm Therapeutics Inc. Q1 FY2026 Earnings Call

Karyopharm Therapeutics Inc. (KPTI)

Earnings Call FY2026 Q1 Call date: 2026-06-13 Concluded

Guidance

from the 8-K filed May 14, 2026
Metric Guided
Total revenue Initiated
full year 2026
$130M – $150M
U.S. XPOVIO Net Product Revenue Initiated
Full-Year 2026
$115M – $130M

Documents & deck